SR-8541A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SR-8541A, covering 2025-06-08 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) [Phase 2]